# Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)

> **NCT02675400** · PHASE4 · COMPLETED · sponsor: **Seattle Children's Hospital** · enrollment: 19 (actual)

## Conditions studied

- Attention Deficit/Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** Vyvanse
- **BEHAVIORAL:** Behavioral Parent Training
- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT02675400
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675400, "Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02675400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*